Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minute Insight: Strados Earns FDA 510(k) To Let Patients Use RESP Sensor At Home

Executive Summary

The FDA cleared Strados’ RESP sensor to be incorporated into at-home remote monitoring of patients with pulmonary disease in addition to in-hospital monitoring. Strados expects the in-home indication will help physicians better understand their patients’ respiratory health “journey.”

You may also be interested in...



Minute Insight: Biotronik Launches Remote Monitor That Can Prevent Heart Failure Hospitalizations

The HeartInsight algorithm combines heart failure parameters into a predictive score and alerts physicians if a patient with an implanted ICD or CRT-D is at higher risk of hospitalization. Biotronik will roll out HeartInsight in Europe in April.

Remote Monitoring A Potential Strategy To Recruit Older Adults Into Oncology Trials

Final FDA guidance also suggests sponsors recruit representative populations and limit exclusions.

Studies On Treating COVID-19 Inflammation And Migraines Also Weigh Efficacy Of Remote Trials

Preliminary data from Cold Springs Harbor Laboratory study suggest famotidine could mitigate inflammatory symptoms of COVID-19 in adults. Research sponsored by Nestle Health Science in Canada also points to remote studies likely to continue after emerging as a pandemic innovation.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT145360

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel